ArticleACS applied materials & interfaces2021
Thermoresponsive Nanocellulose Films as an Optical Modulation Device: Proof-of-Concept.
Article in ACS applied materials & interfaces, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 37 citations in OpenAlex.
- Biophotonic (nano)structures: from fundamentals to emerging applications.RSC advances · 2025Review
- A Comprehensive Review on Cellulose Nanofibers, Nanomaterials, and Composites: Manufacturing, Properties, and Applications.Nanomaterials (Basel, Switzerland) · 2025Review
- Ultrathin Freestanding Nanocellulose Film Prepared from TEMPO-Mediated Oxidation and Homogenized Hydrogel.ACS omega · 2024Article
- Thermochromic Nanocellulose Films for Temperature-Adaptive Passive Cooling.ACS applied materials & interfaces · 2024Article
- Thermal Nanoimprint Lithography-A Review of the Process, Mold Fabrication, and Material.Nanomaterials (Basel, Switzerland) · 2023Review
- Nanocellulose-Based Nanocomposites for Sustainable Applications: A Review.Nanomaterials (Basel, Switzerland) · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Flexible optoelectronic technologies are becoming increasingly important with the advent of concepts such as smart-built environments and wearable systems, where they have found applications in displays, sensing, healthcare, and energy harvesting. Parallelly, there is also a need to make these innovations environmentally sustainable by design. In the present work, we employ nanocellulose and its excellent film-forming properties as a basis to develop a green flexible photonic device for sensing applications. Cellulose nanofibrils (CNFs) and cellulose nanocrystals (CNCs) were used as matrix materials along with a black thermochromic pigment to prepare thermoresponsive hybrid films. Optical properties of nanocellulose films such as transparency and haze were tuned by varying pigment loading. Nearly 90% transparent CNF and CNC films could be tuned to reduce the transmission to as low as 4 and 17%, respectively. However, the films regained transparency to up to 60% when heated above the thermochromic transition temperature (31 °C). The thermoresponsive behavior of the prepared films was exploited to demonstrate an all-optical modulation device. Continuous infrared light (1300 nm) was modulated by using a 660 nm visible diode laser. The laser intensity was sufficient to cause a localized thermochromic transition in the films. The laser was pulsed at 0.3 Hz and a uniform cyclic modulation depth of 0.3 dB was achieved. The demonstrated application of functional nanocellulose hybrid films as a light switch (modulator) could be harnessed in various thermally stimulated sensing systems such as temperature monitoring, energy-saving, and anti-counterfeiting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.